Literature DB >> 18656688

The complicated copy number alterations in chromosome 7 of a lung cancer cell line is explained by a model based on repeated breakage-fusion-bridge cycles.

Kunio Kitada1, Tomoaki Yamasaki.   

Abstract

The drug-resistant lung cancer cell line PTX250, which has been previously established by exposure to an anti-cancer drug paclitaxel, has an increased copy number in the MDR1/ABCB1 locus region. In addition, the flanking regions also exhibit aberrant copy numbers, making the copy number profile of chromosome 7 complicated. In this study, we tested whether the breakage-fusion-bridge (BFB) cycle model can explain such copy number alterations. An analysis using fluorescence in situ hybridization (FISH) with a painting probe demonstrated that the aberrant chromosome, designated chromosome 7(amp), was derived from an intact chromosome 7. Using high-density comparative genomic hybridization arrays, we examined the copy number profile in detail and divided chromosome 7(amp) into seven segments. Based on copy numbers of each segment, which were determined using interphase- and metaphase-FISH analysis, we constructed a formation model for the complicated copy number alteration. Six-time BFB cycles and the cycle-termination by healing of broken ends were presupposed in the model. Locations and orientations of the segments observed in chromosome 7(amp) agreed well with those predicted from the model. Telomere addition was also cytogenetically confirmed. In all, it could be concluded that the complicated copy number alteration found in chromosome 7(amp) is generated from the intact chromosome 7 by the repeated BFB cycles.

Entities:  

Mesh:

Year:  2008        PMID: 18656688     DOI: 10.1016/j.cancergencyto.2008.04.005

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  11 in total

1.  Combinatorics of the breakage-fusion-bridge mechanism.

Authors:  Marcus Kinsella; Vineet Bafna
Journal:  J Comput Biol       Date:  2012-04-16       Impact factor: 1.479

2.  Molecular and cellular pathways associated with chromosome 1p deletions during colon carcinogenesis.

Authors:  Claire M Payne; Cheray Crowley-Skillicorn; Carol Bernstein; Hana Holubec; Harris Bernstein
Journal:  Clin Exp Gastroenterol       Date:  2011-05-03

3.  Reconstructing breakage fusion bridge architectures using noisy copy numbers.

Authors:  Shay Zakov; Vineet Bafna
Journal:  J Comput Biol       Date:  2015-06       Impact factor: 1.479

4.  An algorithmic approach for breakage-fusion-bridge detection in tumor genomes.

Authors:  Shay Zakov; Marcus Kinsella; Vineet Bafna
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-15       Impact factor: 11.205

Review 5.  Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer.

Authors:  David J Stewart
Journal:  Crit Rev Oncol Hematol       Date:  2010-01-04       Impact factor: 6.312

6.  Mre11-Sae2 and RPA Collaborate to Prevent Palindromic Gene Amplification.

Authors:  Sarah K Deng; Yi Yin; Thomas D Petes; Lorraine S Symington
Journal:  Mol Cell       Date:  2015-11-05       Impact factor: 17.970

7.  Overexpression of MEOX2 and TWIST1 is associated with H3K27me3 levels and determines lung cancer chemoresistance and prognosis.

Authors:  Federico Ávila-Moreno; Leonel Armas-López; Aldo M Álvarez-Moran; Zoila López-Bujanda; Blanca Ortiz-Quintero; Alfredo Hidalgo-Miranda; Francisco Urrea-Ramírez; R María Rivera-Rosales; Eugenia Vázquez-Manríquez; Erika Peña-Mirabal; José Morales-Gómez; Juan C Vázquez-Minero; José L Téllez-Becerra; Roberto Ramírez-Mendoza; Alejandro Ávalos-Bracho; Enrique Guzmán de Alba; Karla Vázquez-Santillán; Vilma Maldonado-Lagunas; Patricio Santillán-Doherty; Patricia Piña-Sánchez; Joaquin Zúñiga-Ramos
Journal:  PLoS One       Date:  2014-12-02       Impact factor: 3.240

8.  Potential predictive markers of chemotherapy resistance in stage III ovarian serous carcinomas.

Authors:  Lovisa Osterberg; Kristina Levan; Karolina Partheen; Ulla Delle; Björn Olsson; Karin Sundfeldt; György Horvath
Journal:  BMC Cancer       Date:  2009-10-18       Impact factor: 4.430

9.  Homology-mediated end-capping as a primary step of sister chromatid fusion in the breakage-fusion-bridge cycles.

Authors:  Michael Marotta; Xiongfong Chen; Takaaki Watanabe; Pieter W Faber; Scott J Diede; Stephen Tapscott; Raymond Tubbs; Anna Kondratova; Robert Stephens; Hisashi Tanaka
Journal:  Nucleic Acids Res       Date:  2013-08-23       Impact factor: 16.971

10.  AmpliconReconstructor integrates NGS and optical mapping to resolve the complex structures of focal amplifications.

Authors:  Jens Luebeck; Ceyda Coruh; Siavash R Dehkordi; Joshua T Lange; Kristen M Turner; Viraj Deshpande; Dave A Pai; Chao Zhang; Utkrisht Rajkumar; Julie A Law; Paul S Mischel; Vineet Bafna
Journal:  Nat Commun       Date:  2020-09-01       Impact factor: 17.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.